The novel approach of this peptide represents a significant advance in the management of diabetes mellitus type 2. Distinct from existing medications, tirzepatide targets two pathways – GLP-1 and glucose-dependent https://tirzepatide-peptide460401.howeweb.com/42652936/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment